CDK4/6:

Lian Shu1, Xinhan Cui1, Yan Wang1

  • 1Department of Ophthalmology & Visual Science, Eye & ENT Hospital, Shanghai Medical College, Fudan University, No.83 Fenyang Road, Shanghai, 200031, China.

BMC ophthalmology
|April 14, 2025
PubMed
概括

用于乳腺癌的环素依赖性激酶 (CDK) 4/6 抑制剂可能会导致罕见的状角质病. 这一案例突出了角膜发现,并强调了对这些新型抗癌药物患者的眼部副作用的监测.